Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

1.130 -0.040 (-3.42%)

Streaming Delayed Price Updated: 3:36 PM EDT, Sep 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	115,228
Open	1.168
Bid (Size)	1.120 (2,000)
Ask (Size)	1.130 (1,000)
Prev. Close	1.170
Today's Range	1.110 - 1.170
52wk Range	1.010 - 24.30
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions

August 31, 2026

From Sunshine Biopharma Inc.

Via ACCESS Newswire

A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity

August 26, 2026

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:BNTX),(NYSE:AZN),(NASDAQ:MRNA),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Performance

YTD	-91.2%	-91.2%
1 Month	-3.4%	-3.4%
3 Month	-57.5%	-57.5%
6 Month	-90.2%	-90.2%
1 Year	-92.2%	-92.2%

More News

A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity

August 26, 2026

From MarketNewsUpdates.com

Via GlobeNewswire

Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer

August 26, 2026

From Sunshine Biopharma Inc.

Via ACCESS Newswire

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market

August 19, 2026

From Sunshine Biopharma Inc.

Via ACCESS Newswire

Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market

August 07, 2026

From Sunshine Biopharma Inc.

Via ACCESS Newswire

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval

August 04, 2026

From Sunshine Biopharma Inc.

Via ACCESS Newswire

Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting

July 28, 2026

From Sunshine Biopharma Inc.

Via ACCESS Newswire

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings

July 20, 2026

From Sunshine Biopharma Inc.

Via ACCESS Newswire

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

June 25, 2026

From Sunshine Biopharma Inc.

Via ACCESS Newswire

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

June 01, 2026

Via ACCESS Newswire

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

May 29, 2026

Via ACCESS Newswire

Thursday's session: top gainers and losers ↗

May 28, 2026

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

May 28, 2026

Via Chartmill

Which stocks are gapping on Thursday? ↗

May 28, 2026

Via Chartmill

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

May 28, 2026

Via ACCESS Newswire

Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW!

May 26, 2026

Via AB Newswire

ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness

May 26, 2026

Via AB Newswire

Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch

May 26, 2026

Via AB Newswire

What's going on in today's after hours session ↗

May 21, 2026

Via Chartmill

Most active stocks in Thursday's session ↗

May 21, 2026

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

May 21, 2026

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

May 21, 2026

Via Chartmill

Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin ↗

May 21, 2026

Via Benzinga

What's going on in today's pre-market session ↗

May 21, 2026

Via Chartmill

Frequently Asked Questions

Is Sunshine Biopharma Inc. - Common stock publicly traded?

Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.

What exchange does Sunshine Biopharma Inc. - Common stock trade on?

Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?

The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market

What is the current price of Sunshine Biopharma Inc. - Common stock?

The current price of Sunshine Biopharma Inc. - Common stock is 1.130

When was Sunshine Biopharma Inc. - Common stock last traded?

The last trade of Sunshine Biopharma Inc. - Common stock was at 09/03/26 03:36 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.